quantisnow
FeedTopReportsPricing
⌘K
Live feed
07:00:50·199d
SECFiling
I-MAB logo

SEC Form 6-K filed by I-MAB

IMAB· I-MAB
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • IMAB
    I-MAB
    Health Care

Recent analyst ratings

  • Oct 3UpdateLeerink Partners$9.00
  • Sep 9UpdateBTIG Research$7.00
  • Dec 9UpdateSiebert Williams Shank$96.00
  • Nov 1UpdateNeedham$85.00
  • Sep 1UpdateHC Wainwright & Co.$95.00

Related

  • SEC175d
    SEC Form 6-K filed by I-MAB
  • SEC176d
    SEC Form 6-K filed by I-MAB
  • SEC176d
    SEC Form 6-K filed by I-MAB
  • PR176d
    I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform
  • SEC177d
    SEC Form 6-K filed by I-MAB
  • SEC181d
    SEC Form 6-K filed by I-MAB
  • SEC181d
    SEC Form 6-K filed by I-MAB
  • SEC181d
    Amendment: SEC Form 6-K/A filed by I-MAB
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022